to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
The crown jewel of the U.S. university system – the finest in the world – is the research university, where knowledge creation is the ultimate goal. Recognition of the centrality of knowledge creation to economic growth makes the efficiency of university innovation a top concern to policymakers, especially since the federal government funds two-thirds of the $48 billion of R&D performed in academic institutions. In too many universities, commercialization of research discoveries is not as rapid or as successful as it could be. The solution provided by Technology Transfer Offices (TTO) has been mixed, as too many have been directed to focus on maximizing revenue through patent licensing, leading to a sub-optimal level of technology diffusion. In the face of declining funding of basic science research, venture capital migration to downstream opportunities, and heightened competition from abroad, the optimal commercialization of U.S. university innovations could not be more important.
Developing the human capital of young Americans is vital to keep America’s entrepreneurial economy growing. Our future entrepreneurs and their workers need the twenty-first century skills and knowledge to create successful ventures and to spur innovation in the economy. Yet education in the U.S. is struggling to stay competitive and fails to provide access to a quality educational experience for all students. Developing tomorrow’s talented, capable innovators is a challenge that will require major, entrepreneurially-driven improvements in education from pre-school through graduate school.
What's the best strategy for developing and launching a new medical device? The uncertainty of the regulatory and reimbursement environment in the United States has made venture capitalists wary of investing in new medical device companies, but that doesn't mean all is lost.
Data sharing can bring down healthcare costs, says a new Kauffman Foundation report. Read about open access to medical data.
Before you create a medical device prototype, you should know which form of FDA approval it will need. Read about the FDA approval process.
Chief Technology Officer Aneesh Chopra says U.S. healthcare reform is driving changes in the healthcare market that create new entrepreneurial opportunities.
Is your digital health startup subject to HIPAA regulations? Here's a quick HIPAA overview for startups.
Proposed federal budget cuts could hurt healthcare innovation in America and be bad for patients. Read more to find out why giving Medicare the power to negotiate drug prices is a bad idea.
Timothy C. Draper is the Founder and a Managing Director of Draper Fisher Jurvetson. He was instrumental in bringing viral marketing to web-based e-mail to geometrically spread the successes of Hotmail and YahooMail, and the practice has been adopted as a standard marketing technique by countless businesses and organizations. Draper launched the DFJ Global Network, an international network of early-stage venture capital funds with offices in over 30 cities around the globe. He also serves on the boards of Skype, SocialText, Project Y, MailFrontier and Chroma Graphics. He was an original investor in Parametric Technology (PMTC), Tumbleweed Communications (TMWD), Overture.com (OVER), Digidesign (AVID), Preview Travel (TVLY), Four11 (YHOO), Combinet (CSCO), and Redgate (AOL). He also founded or co-founded Wasatch Ventures (Salt Lake City), Zone Ventures (LA), Draper Atlantic (Reston), Draper Triangle (Pittsburg), Timberline Ventures (Portland), Polaris Fund (Anchorage), Draper Fisher Jurvetson Gotham (NYC) and DFJ Frontier (Sacramento and Santa Barbara). Draper has been recognized as a leader in entrepreneurship and venture capital through numerous awards and honors, and he has frequent TV, radio, and headline appearances. He was number seven on Forbes? Midas List and number 52 on the list of the most influential Harvard Alumni. He was also named AlwaysOn Magazine?s number one top venture capital dealmaker for 2008. Tim is the course creator and Chairman of BizWorld, a 501c3 organization built around simulated teaching of entrepreneurship and business to children. He holds a BS in Electrical Engineering from Stanford University, and an MBA from Harvard Business School.
FDA medical device user fees will more than double during the next five years. Read more about why the FDA is increasing its fees.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
